Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
about
Beta-blockers for hypertensionBeta-blockers for hypertensionEffects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-AnalysisScope of heart failure hospitalizationBeta-blockers for hypertension.Transfusion practice in the intensive care unit: a 10-year analysis.Event-free survival in adults with heart failure who engage in self-care management.Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization.Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction.A practical guide for the treatment of symptomatic heart failure with reduced ejection fraction (HFrEF).Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failureLessons from the management of chronic heart failure.Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study.Out-patient management of chronic heart failure.Early initiation of beta blockade in heart failure: issues and evidence.Optimizing treatment and outcomes in acute heart failure: beyond initial triage.The Prevention of Hospital Readmissions in Heart FailureCarvedilol: use in chronic heart failure.Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.Clinical Research on Brain Natriuretic Peptide Guiding the Application of β1 Receptor Blocker in Patients with Moderate to Severe Heart FailureBeta-blocker therapy of heart failure: an update.Current guidelines for treatment of heart failure: 2006 update.Underutilization of evidence-based therapies in heart failure: the pharmacist's role.Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.Carvedilol in the treatment of elderly patients with chronic heart failure.Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality MeasuresChronic heart failure: we are fighting the battle, but are we winning the war?Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6.Role of carvedilol controlled-release in cardiovascular disease.Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity iEfficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia.Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure.Can we improve the treatment of congestion in heart failure?A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.Acute decompensated heart failure: evolving literature and implications for future practice.National prescribing trends for heart failure medications in children.Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.Hospital readmission in heart failure, a novel analysis of a longstanding problem.
P2860
Q24201511-564B318E-625E-47F4-B5C0-350559FDF6AAQ24202812-20EDEF7F-784E-43F0-A7FE-267666BBD40BQ26801321-ECED1DEA-9F83-43DD-9B81-B5D39B9D70EAQ27022922-BEC6148E-0839-42E0-BA5C-0D5DF0FB69E1Q30238911-01F56D45-2B2B-4DFC-8C3E-BFB6FA356C0CQ34145971-BEABE867-FDF5-4C22-BF26-D2CF03EE929FQ34148130-51B42705-4768-4D57-9585-098A4D7DD230Q34307931-33227485-B39D-49AE-8791-B24DA63389E4Q34599841-559BDB82-FFA8-488A-98C3-5EE0D6182822Q35139947-E9834138-9BBE-4C16-BC5E-8EBB6B9AAEB1Q35771399-3158D7C2-BC57-4A53-84C8-AB12326A7149Q35808265-B8D9B340-5144-4976-A06C-A953DCDDDB3BQ36023194-13C0CEE6-CE51-4CB7-842E-04A19A05084EQ36249926-F922266C-0C9A-483E-A048-ADF2FEDE5FB9Q36287752-DBA85EB7-FA17-472B-BAD9-BB8E13CF854AQ36499953-608E9AB9-7AB5-4704-AFB1-04E6FD407AC0Q36665264-41C4DD36-BD6D-4F56-B3BE-038F62D9B8F6Q36691623-E7436A70-B7EB-499E-B897-029AEA163B3BQ36716456-6BE0B6EA-EDD7-476C-AC88-9E575DFA4838Q36721581-F9E71E0F-D5AB-4EC1-9A17-FC3A67D4E468Q36723828-60E695BE-8530-4202-82DA-1B7CE6D2A465Q36768249-A0A87C1C-1A15-42D9-9F04-411E157FB310Q36768252-72FB2F06-6857-4134-A2DA-E77A8594FFEEQ36773341-BCD047E9-129D-452F-9F74-A276E687452CQ36811824-C5735372-C597-466A-BEBB-5ACE54027E18Q36892905-FF68C3A5-9143-430D-8819-9B2DC7748891Q37085456-AAC5820E-2340-44B6-8973-4CDAC9494A42Q37288386-3CA378F6-226B-4258-AF5F-3EEEF3B14BE3Q37354429-23C1CFBC-66DA-4EC1-9CFF-4D26E804973DQ37461040-444316D0-8F8C-484F-AC11-C49E79A6CEC8Q37472042-6329A39C-FF1F-4094-B7AB-4BAAC3C1B14DQ37653092-9BA2C972-AA8D-4965-8458-46E63A474DB0Q37737193-592D5664-EFBA-4E3C-9BDB-820BED2F5BABQ37786547-95EA3B8C-AC40-4779-9951-F9ECE61AB935Q37845856-3AD7C02B-45B4-483A-8E5B-EA62E7E0CD04Q38075586-5D39B087-FB30-4F58-B169-E27A9B62D4DDQ38161451-C066CEA0-A852-426C-B249-D590CD25EACEQ38204017-D388549E-19FD-4B84-AC1C-76EBBC90A751Q38254025-54B0C7F1-8F4F-408D-8A2C-7CFC0B6EBCC6Q38257320-EFF9E36E-5429-469B-AD97-830D73144578
P2860
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Predischarge initiation of car ...... art Failure (IMPACT-HF) trial.
@en
Predischarge initiation of car ...... dilol Therapy in Heart Failure
@nl
type
label
Predischarge initiation of car ...... art Failure (IMPACT-HF) trial.
@en
Predischarge initiation of car ...... dilol Therapy in Heart Failure
@nl
prefLabel
Predischarge initiation of car ...... art Failure (IMPACT-HF) trial.
@en
Predischarge initiation of car ...... dilol Therapy in Heart Failure
@nl
P2093
P50
P921
P1476
Predischarge initiation of car ...... art Failure (IMPACT-HF) trial.
@en
P2093
Dianne S Gallup
IMPACT-HF Investigators and Coordinators
Wendy A Gattis
P304
P356
10.1016/J.JACC.2003.12.040
P407
P577
2004-05-01T00:00:00Z